期刊文献+

基于网络药理学的淫羊藿防治疾病的优效组分及信号通路研究 被引量:20

Effective components and signaling pathways of Epimedium brevicornum based on network pharmacology
原文传递
导出
摘要 该研究采用网络药理学技术筛选出中药淫羊藿防治疾病的活性组分,并对潜在的靶点与机制进行整合与分析。采用TCMSP数据库筛选活性成分,利用TTD和DrugBank数据库配合文献挖掘潜在靶点进行预测,利用通路注释技术对淫羊藿中活性成分及潜在靶点进行通路的富集与分析。该研究共筛选出淫羊藿中具有潜在靶点的活性成分34个,主要包括淫羊藿苷,朝藿定A,朝藿定B,朝藿定C,淫羊藿A,淫羊藿C在内的21个黄酮类组分;(+)-cycloolivil和olivil在内的木脂素类组分以及谷甾醇、24-epicampesterol和poriferast-5-en-3beta-ol在内的甾醇类组分。另外,筛选出与之相对应的作用靶点183个,主要包含Ptgs2,NCOA6,RANK,OPG,WNT9B,PTH1R,BMPs,SMAD4A等;共涉及信号通路84条,如NF-κB信号通路、T细胞受体信号通路、IL-17信号通路等在内的8条炎症相关通路,乳腺癌、膀胱癌、胰腺癌在内的10条肿瘤疾病类相关通路以及与雌激素信号通路在内的内分泌等相关通路。这为淫羊藿活性组分的发现及作用机制研究奠定了基础。 The aim of this paper was to find out the active components of Epimedium brevicornum using network pharmacology, and find the potential targets and mechanisms. The TCMSP database was used to screen the active ingredients, and TTD and DrugBank databases were used to predict the potential targets with the literature mining. The pathway annotation was used to enrich and analyze the active ingredients and potential targets of E. brevicornum. The results showed that E. brevicornum had34 potential target active ingredients, including 21 flavones components, such as icariin, epimedin A, epimedin B, epimedin C, Yinyanghuo A, Yinyanghuo C and so on, 2 lignans involved in(+)-cycloolivil and olivil, 3 sterols consisting of sitosterol, 24-epicampesterol and poriferast-5-en-3 beta-ol. The main predicted targets included Ptgs2, NCOA6, RANK, OPG, WNT9 B, PTH1 R, BMPs, SMAD4 A and so on. There were 88 signaling pathways involved in 10 signaling pathways which was related to inflammation, such as NF-kappa B signaling pathway, T cell receptor signaling pathway, IL-17 signaling pathway and 10 pathways which was related to cancer included breast cancer, bladder cancer, pancreatic cancer and so on, and estrogen related signaling pathways included estrogen signaling pathway. This laid the foundation for the discovery of the active components of Epimedium and the study on its mechanism of action.
作者 张润桐 吴海宁 于桂红 周园里 贾晓斌 封亮 ZHANG Run-tong;WU Hai-ning;YU Gui-hong;ZHOU Yuan-li;JIA Xiao-bin;FENG liang(Key Laboratory of New Drug Delivery System of Chinese Materia Medica,Jiangsu Provincial Academy of Chinese Medicine,Nanjing 210028,China;School of Chinese Medicine Pharmacy,China Pharmaceutical University,Nanjing 211198,China)
出处 《中国中药杂志》 CAS CSCD 北大核心 2018年第23期4709-4717,共9页 China Journal of Chinese Materia Medica
基金 国家“重大新药创制”科技重大专项(2017ZX09301051) 国家公益行业专项(201507004) 国家中医临床研究基地业务建设第二批科研专项(JDZX2015K01) 江苏省青年医学重点人才项目(QNRC2016634)
关键词 淫羊藿 网络药理学 成分-靶点 组分发现 Epimedium brevicornum network pharmacology component-target component discovery
  • 相关文献

参考文献16

二级参考文献355

共引文献625

同被引文献333

引证文献20

二级引证文献342

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部